1-13 of 13
Bruno Lacarelle
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 3000: Impact of trastuzumab coating when prototyping immunoliposomes in breast cancer models: The more the merrier

Anne Rodallec, Corentin Franco, Stéphane Robert, Guillaume Sicard, Sarah Giacometti, Ariel Savina, Fanny Bouquet, Bruno Lacarelle, Joseph Ciccolini, Philippe Poncelet, Raphaelle Fanciullino
Journal: Cancer Research
Cancer Res (2019) 79 (13_Supplement): 3000.
DOI: https://doi.org/10.1158/1538-7445.AM2019-3000
Published: 01 July 2019
View article
Journal Articles

Abstract 3709: Characterization, in vitro and in vivo efficacy studies of docetaxel trastuzumab stealth immunoliposome in human breast cancer models

Anne Rodallec, Jean Michel Brunel, Stephane Robert, Sarah Giacometti, Ariel Savina, Fanny Bouquet, Bruno Lacarelle, Joseph Ciccolini, Raphaelle Fanciullino
Journal: Cancer Research
Cancer Res (2018) 78 (13_Supplement): 3709.
DOI: https://doi.org/10.1158/1538-7445.AM2018-3709
Published: 01 July 2018
View article
Journal Articles

Abstract 3892: Upfront DPD screening with adaptive dosing to secure 5-FU administration in head and neck cancer patients

Joseph Ciccolini, Manon Launay, Charlotte Dupuis, Florence Duffaud, Bruno Lacarelle, Sébastien Salas
Journal: Cancer Research
Cancer Res (2018) 78 (13_Supplement): 3892.
DOI: https://doi.org/10.1158/1538-7445.AM2018-3892
Published: 01 July 2018
View article
Journal Articles

Abstract 3898: CDA predicts life-threatening toxicities in AML patients treated with cytarabine

Raphaelle Fanciullino, Laure Farnault, Mélanie Donnette, Vadim Ivanov, Geoffroy Venton, Joseph Ciccolini, Yael Berda-Haddad, Catherine Roche, L'Houcine Ouafik, Bruno Lacarelle, Regis Costello
Journal: Cancer Research
Cancer Res (2018) 78 (13_Supplement): 3898.
DOI: https://doi.org/10.1158/1538-7445.AM2018-3898
Published: 01 July 2018
View article
Journal Articles

Abstract 5048: Residual concentrations of cetuximab predict clinical response in head and neck cancer patients

Joseph Ciccolini, François Becher, Diane-Charlotte Imbs, Claire Fournel, Florence Duffaud, Bruno Lacarelle, Sebastien Salas
Journal: Cancer Research
Cancer Res (2017) 77 (13_Supplement): 5048.
DOI: https://doi.org/10.1158/1538-7445.AM2017-5048
Published: 01 July 2017
View article
Journal Articles

Abstract 5479: PGx of gemcitabine in pancreatic ADK: Where did we go wrong

Cindy SERDJEBI, Florence GATTACCECA, Martina SCHNEIDER, Carole MONTERYMARD, Jaic CARIO, Karine LE MALICOT, Madani RACHID, Bruno LACARELLE, Jean-François SEITZ, Joseph CICCOLINI, Laetitia DAHAN
Journal: Cancer Research
Cancer Res (2015) 75 (15_Supplement): 5479.
DOI: https://doi.org/10.1158/1538-7445.AM2015-5479
Published: 01 August 2015
View article
Journal Articles

Abstract 5555: Pharmacogenetics-pharmacokinetics study of bevacizumab in mCRC patients treated with Avastin-Folfiri regimen: Search for predictive markers of response and study of the pharmacokinetics variability

Anne-Sophie Chantry, Joseph Ciccolini, Camille Sibertin-Blanc, Laetitia Dahan, Sylviane Olschwang, Jean-François Seitz, Bruno Lacarelle
Journal: Cancer Research
Cancer Res (2014) 74 (19_Supplement): 5555.
DOI: https://doi.org/10.1158/1538-7445.AM2014-5555
Published: 01 October 2014
View article
Journal Articles

Abstract 5549: Recipient-donor contradictory genotype with impact on anticancer drug pharmacogenetics after liver transplant: A deadly gift

Cindy Serdjebi, Raphaelle Fanciullino, Frederic Fina, Arnaud Verschuur, Bertrand Roquelaure, Bruno Lacarelle, L'Houcine Ouafik, Joseph Ciccolini, Nicolas André
Journal: Cancer Research
Cancer Res (2014) 74 (19_Supplement): 5549.
DOI: https://doi.org/10.1158/1538-7445.AM2014-5549
Published: 01 October 2014
View article
Journal Articles

Abstract 2204: DPD for dummies: efficacy and toxicity in digestive cancer patients with pharmacogenetic-driven adaptive dosing of 5-FU.

Joseph Ciccolini, Laetitia Dahan, Alexandre Evrard, Muriel Duluc, Emmanuelle Norguet, Bruno Lacarelle, Jean-François Seitz
Journal: Cancer Research
Cancer Res (2013) 73 (8_Supplement): 2204.
DOI: https://doi.org/10.1158/1538-7445.AM2013-2204
Published: 15 April 2013
View article
Journal Articles

Abstract 1869: Severe toxicities in patients undergoing gemcitabine, ARA-C, capecitabine, or azacytidine treatments: Is deregulated cytidine deaminase the bad guy

Cindy Serdjebi, Joseph Ciccolini, Alexandre Evrard, Cedric Mercier, Nicolas André, Laetitia Dahan, Gerard Milano, Jean-François Seitz, Bruno Lacarelle, L'Houcine Ouafik
Journal: Cancer Research
Cancer Res (2012) 72 (8_Supplement): 1869.
DOI: https://doi.org/10.1158/1538-7445.AM2012-1869
Published: 15 April 2012
View article
Journal Articles

Implication of DPD deficiency in severe or lethal toxicities after 5-fluorouracil and capecitabine-based chemotherapies

Joseph Ciccolini, Cédric Mercier, Laetitia Dahan, Florence Duffaud, Jean-François Seitz, Roger Favre, Gérard Milano, Bruno Lacarelle
Journal: Cancer Research
Cancer Res (2005) 65 (9_Supplement): 942.
Published: 01 May 2005
View article
Journal Articles

Administration of capecitabine plus 3-weekly oxaliplatin (XELOX) in a patient with dihydropyrimidine dehydrogenase (DPD) deficiency

Joseph Ciccolini, Laetitia Dahan, Alexandre Evrard, Cédric Mercier, Jean-Christophe Boyer, Jean-Philippe Dales, Gérard Milano, Jean François Seitz, Bruno Lacarelle
Journal: Cancer Research
Cancer Res (2005) 65 (9_Supplement): 942.
Published: 01 May 2005
View article
Journal Articles

Predicting dihydropyrimidine deshydrogenase (DPD) deficiency in cancer patients: Enzymatic activity in lymphocytes vs uracil/dihydrouracil (U/UH2) ratio determination in plasma

Joseph Ciccolini, Marie-Christine Etienne-Grimaldi, Nicole Renée, Jean-Louis Formento, Pierre Cuq, Maurice Schneider, Bruno Lacarelle, Gérard Milano
Journal: Cancer Research
Cancer Res (2005) 65 (9_Supplement): 942.
Published: 01 May 2005
View article